MX2013003028A - Capacitating culture medium comprising calmodulin and atp. - Google Patents
Capacitating culture medium comprising calmodulin and atp.Info
- Publication number
- MX2013003028A MX2013003028A MX2013003028A MX2013003028A MX2013003028A MX 2013003028 A MX2013003028 A MX 2013003028A MX 2013003028 A MX2013003028 A MX 2013003028A MX 2013003028 A MX2013003028 A MX 2013003028A MX 2013003028 A MX2013003028 A MX 2013003028A
- Authority
- MX
- Mexico
- Prior art keywords
- capacitating
- atp
- culture medium
- calmodulin
- piperazineethanosulfonic
- Prior art date
Links
- 102000000584 Calmodulin Human genes 0.000 title abstract 3
- 108010041952 Calmodulin Proteins 0.000 title abstract 3
- 239000001963 growth medium Substances 0.000 title abstract 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 abstract 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 abstract 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 abstract 1
- 239000007995 HEPES buffer Substances 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention refers to capacitating culture medium containing calmodulin (CaM), adenosine triphosphate (ATP), and optionally, one or more complementary agents such as 4-(hydroxyethyl)-1-piperazineethanosulfonic acid (HEPES).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2013003028A MX2013003028A (en) | 2013-03-15 | 2013-03-15 | Capacitating culture medium comprising calmodulin and atp. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2013003028A MX2013003028A (en) | 2013-03-15 | 2013-03-15 | Capacitating culture medium comprising calmodulin and atp. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2013003028A true MX2013003028A (en) | 2014-09-22 |
Family
ID=52346979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013003028A MX2013003028A (en) | 2013-03-15 | 2013-03-15 | Capacitating culture medium comprising calmodulin and atp. |
Country Status (1)
| Country | Link |
|---|---|
| MX (1) | MX2013003028A (en) |
-
2013
- 2013-03-15 MX MX2013003028A patent/MX2013003028A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY184733A (en) | Pyrimidine fgfr4 inhibitors | |
| HRP20190152T1 (en) | Combination of pyrrolo [2, 3 -d]pyrimidine derivatives with one or more additional agents as inhibitors of janus- related kinases (jak) | |
| PH12017501413A1 (en) | Substituted nucleoside derivatives useful as anticancer agents | |
| MX374191B (en) | 4'-DIFLUOROMETHYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF INFLUENZA RNA REPLICATION. | |
| MX2018003353A (en) | Car t cell therapies with enhanced efficacy. | |
| UY34824A (en) | NUCLEOSIDES OF URACILO SPYROOXETHANE | |
| MX2016000143A (en) | Fused tricyclic urea compounds as raf kinase and/or raf kinase dimer inhibitors. | |
| MX2016007541A (en) | Modified nucleic acid molecules and uses thereof. | |
| TR201911140T4 (en) | Heteroaryl compounds and their uses as Btk inhibitors. | |
| MX373365B (en) | AMINOPYRIDINE DERIVATIVES AS INHIBITORS OF TYRO3, AXL AND MER FAMILY KINASES (TAM). | |
| TR201908247T4 (en) | Sodium glucose co-transporter 1 inhibitors. | |
| CU20180027A7 (en) | PIRROLO DERIVATIVES [2,3-d] PYRIMIDINE, USEFUL AS DOUBLE INHIBITORS OF DYRK 11CLK1 AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| EA201491647A1 (en) | BASED ON ARILETHER KINAZ INHIBITORS | |
| GEP20166489B (en) | 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors | |
| MY197646A (en) | Compositions and methods for inhibiting expression of the alas1 gene | |
| BR112015001890A2 (en) | aryl lactam kinase inhibitors | |
| NZ731344A (en) | Hydroxyl purine compounds and applications thereof | |
| EA201690244A1 (en) | KINAZ INHIBITORS BASED ON SIMPLE ARYL ETHERS | |
| BR112017009629A2 (en) | triazolo [4,5-d] pyrimidines as cannabinoid receptor 2 agonists | |
| MA39824A (en) | Amido-substituted azole compounds as inhibitors of tnks1 and/or tnks2 | |
| MX377829B (en) | COMPOUNDS WITH PESTICIDAL ACTIVITY. | |
| MX2013003028A (en) | Capacitating culture medium comprising calmodulin and atp. | |
| AR101915A1 (en) | INTERMEDIARIES AND PROCESSES FOR THE PREPARATION OF COMPOUNDS | |
| TWD175252S (en) | Rear doors for automobiles | |
| WO2014172583A3 (en) | Compositions and methods utilizing phosphodiesterase inhibitors to treat blast-induced tinnitus and/or hearing loss |